Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 28 studies | 36% ± 18% | |
macrophage | 17 studies | 34% ± 14% | |
oligodendrocyte precursor cell | 15 studies | 65% ± 19% | |
glutamatergic neuron | 11 studies | 41% ± 22% | |
GABAergic neuron | 10 studies | 44% ± 19% | |
astrocyte | 10 studies | 35% ± 18% | |
endothelial cell | 9 studies | 33% ± 13% | |
adipocyte | 9 studies | 30% ± 9% | |
conventional dendritic cell | 8 studies | 25% ± 7% | |
classical monocyte | 8 studies | 24% ± 11% | |
connective tissue cell | 7 studies | 22% ± 8% | |
monocyte | 7 studies | 32% ± 14% | |
type II pneumocyte | 7 studies | 53% ± 17% | |
epithelial cell | 6 studies | 29% ± 15% | |
interneuron | 6 studies | 41% ± 22% | |
microglial cell | 6 studies | 34% ± 20% | |
dendritic cell | 6 studies | 31% ± 12% | |
myeloid cell | 6 studies | 26% ± 8% | |
non-classical monocyte | 5 studies | 21% ± 8% | |
hepatocyte | 5 studies | 64% ± 30% | |
pericyte | 5 studies | 33% ± 15% | |
mononuclear phagocyte | 5 studies | 30% ± 11% | |
type I pneumocyte | 5 studies | 17% ± 2% | |
neuron | 4 studies | 38% ± 19% | |
smooth muscle cell | 4 studies | 39% ± 21% | |
hepatic stellate cell | 3 studies | 39% ± 16% | |
GABAergic interneuron | 3 studies | 28% ± 8% | |
progenitor cell | 3 studies | 44% ± 13% | |
retinal ganglion cell | 3 studies | 24% ± 5% | |
adventitial cell | 3 studies | 42% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 3507.66 | 226 / 226 | 98% | 33.49 | 397 / 406 |
prostate | 99% | 2331.29 | 243 / 245 | 95% | 17.68 | 476 / 502 |
brain | 85% | 1502.68 | 2242 / 2642 | 100% | 99.59 | 704 / 705 |
adrenal gland | 100% | 3228.52 | 258 / 258 | 83% | 27.16 | 192 / 230 |
intestine | 100% | 3458.35 | 965 / 966 | 83% | 16.88 | 439 / 527 |
lung | 99% | 2143.10 | 570 / 578 | 75% | 11.88 | 870 / 1155 |
stomach | 85% | 2309.53 | 305 / 359 | 72% | 15.35 | 207 / 286 |
breast | 100% | 3087.60 | 457 / 459 | 52% | 5.00 | 577 / 1118 |
esophagus | 92% | 2478.81 | 1325 / 1445 | 54% | 6.80 | 98 / 183 |
pancreas | 60% | 484.18 | 198 / 328 | 80% | 11.40 | 143 / 178 |
bladder | 100% | 3487.86 | 21 / 21 | 40% | 7.13 | 204 / 504 |
uterus | 99% | 2972.35 | 169 / 170 | 36% | 4.81 | 165 / 459 |
thymus | 98% | 2012.00 | 637 / 653 | 22% | 3.55 | 135 / 605 |
ovary | 100% | 2675.61 | 180 / 180 | 20% | 1.71 | 85 / 430 |
skin | 98% | 2265.48 | 1777 / 1809 | 13% | 1.34 | 62 / 472 |
blood vessel | 100% | 5041.42 | 1333 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 3317.10 | 1202 / 1204 | 0% | 0 | 0 / 0 |
spleen | 88% | 937.48 | 212 / 241 | 0% | 0 | 0 / 0 |
heart | 87% | 1065.22 | 746 / 861 | 0% | 0 | 0 / 0 |
kidney | 44% | 394.63 | 39 / 89 | 31% | 2.70 | 281 / 901 |
muscle | 73% | 783.82 | 584 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 24% | 2.14 | 7 / 29 |
peripheral blood | 20% | 173.83 | 190 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 20% | 2.21 | 9 / 45 |
eye | 0% | 0 | 0 / 0 | 11% | 0.69 | 9 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_2000377 | Biological process | regulation of reactive oxygen species metabolic process |
GO_2001170 | Biological process | negative regulation of ATP biosynthetic process |
GO_0045444 | Biological process | fat cell differentiation |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0046627 | Biological process | negative regulation of insulin receptor signaling pathway |
GO_0070346 | Biological process | positive regulation of fat cell proliferation |
GO_0051881 | Biological process | regulation of mitochondrial membrane potential |
GO_0071356 | Biological process | cellular response to tumor necrosis factor |
GO_0001933 | Biological process | negative regulation of protein phosphorylation |
GO_0071345 | Biological process | cellular response to cytokine stimulus |
GO_0007005 | Biological process | mitochondrion organization |
GO_0044320 | Biological process | cellular response to leptin stimulus |
GO_2000379 | Biological process | positive regulation of reactive oxygen species metabolic process |
GO_0046325 | Biological process | negative regulation of glucose import |
GO_0071398 | Biological process | cellular response to fatty acid |
GO_0010635 | Biological process | regulation of mitochondrial fusion |
GO_0006112 | Biological process | energy reserve metabolic process |
GO_2001171 | Biological process | positive regulation of ATP biosynthetic process |
GO_0071354 | Biological process | cellular response to interleukin-6 |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_1903077 | Biological process | negative regulation of protein localization to plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
Gene name | PID1 |
Protein name | PTB-containing, cubilin and LRP1-interacting protein (P-CLI1) (Phosphotyrosine interaction domain-containing protein 1) (Protein NYGGF4) Phosphotyrosine interaction domain containing 1 |
Synonyms | HMFN2073 NYGGF4 PCLI1 |
Description | FUNCTION: Increases proliferation of preadipocytes without affecting adipocytic differentiation. . |
Accessions | ENST00000392055.8 [Q7Z2X4-4] ENST00000392054.7 [Q7Z2X4-2] F5H314 Q7Z2X4 ENST00000534952.1 ENST00000354069.6 [Q7Z2X4-1] ENST00000409462.1 [Q7Z2X4-3] |